|
Fast
forward into the future
The centre of gravity seems to be shifting from developed
to emerging economies. And China is one of them, which is
slated to contribute 15 percent of world GDP by 2025. Quite
a few countries who have truly grasped the magnitude, multi-faceted
nature and speed of this change are eyeing the Chinese pharmaceutical
market. Arshiya Khan reports
Indoco
to supply 500 mn anti-diabetic tabs per annum to Germany
Indoco Remedies will supply 500 million metformin, anti-diabetic
tablets per annum to Germany for two years towards the AOK
(Allgemeine Ortskranken-kassen) tender, The Health Fund of
Germany
Exploring
opportunities to create awareness in the market
Most of India's leading pharmaceutical companies have suffered
badly in the last quarter due to forex exchange losses. Being
just nine months old currency derivatives MCX Stock Exchange,
a new financial product in the Indian capital market is the
new mantra to manage forex losses through hedging. Sanjit
Prasad, Chief Business Officer, MCX' SX shares profitability
tips with Usha Sharma
Mexican
health ministry seeks support from Lanxess to combat swine
flu
German specialty chemicals group Lanxess is working with a
commission from the Mexican health ministry to provide possible
solutions to the swine flu outbreak that has swept through
Mexico with cases currently reported in many other countries
worldwide
Three
IND approvals in DRL's basket
Dr Reddy's Laboratories (DRL) announced that the first human
subjects were successfully dosed in a phase I study with DRL
17822, a selective inhibitor of CETP, for the treatment of
dyslipidemia, atherosclerosis and associated cardiovascular
diseases
PLSL
kicks off phase I trial for diabetes metabolic syndrome in
Canada
Piramal Life Sciences (PLSL) has commenced phase I trial of
a new experimental drug molecule P2202 for diabetes-metabolic
syndrome in Canada
Ranbaxy
acquires Ochoa Laboratories
Ranbaxy Laboratories has acquired trademarks, product dossiers
and marketing rights from Ochoa Laboratories (Ochoa), a medium
sized pharmaceutical formulations and dosage forms manufacturer
located on the outskirts of New Delhi for its entire range
of dermatological and lifestyle products
Ajanta
Pharma to commission its API facility in September 09
The Rs 323 crore Mumbai-based pharmaceutical company Ajanta
Pharma is investing Rs 28 crore for setting up new Active
Pharmaceutical Ingredient (API) facility for high volume products
at Walunj, Aurangabad
FICCI
to promote Indian clinical trials industry at 45th annual
DIA meeting
An impetus for the industry, this is for the first time in
the history that the Indian clinical trials industry sees
Government support towards its promotion abroad
Event
Brief
HCF
REACHes towards successful, sustainable chemistry
In many ways, Helsinki may seem to be the last place on earth
to hold a conference dealing with chemicals. Traditionally
a land of dense pine forests, with a lot of its green cover
still intact, framed by its picturesque archipelago, Finland
has successfully dealt with the Baltic Sea, reportedly the
most polluted sea in the world
Knowing
patents the right way
In continuation of a series of patent awareness programmes,
Pharmaceuticals Export Promotion Council (Pharmexcil) held
a 'Patent Awareness Seminar' on May 26, at Chandigarh, where
eminent speakers in the pharma patents field, namely, Dr Gopakumar
G Nair, Advisor, Pharmexcil, Feroz Ali, Advocate, Chennai,
and Andreya Fernandes, Gopakumar Nair Associates, made presentations
on the Indian and International patent scenario in the pharma
sector
FOPE
organises seminar on GLP
The Federation of Pharma Entrepreneurs (FOPE) a Federation
of Tax Free Pharma Units, organised a one day seminar on Good
Laboratory Practices (GLP) on May 30, at PHD Chambers of Commerce
& Industry, PHD House, Chandigarh with a view to update
its member units on the importance of impending GLP norms,
which have been notified and are to be implemented with effect
from November 1, 2010
|
